Recent Finacing
Recent Raise
caprotec bioanalytics GmbH develops and commercializes a proprietary Capture Compound Mass Spectrometry (CCMS) platform and products (caproKits, ImproMed) to analyze small‑molecule–protein interactions for functional proteomics, drug and biomarker development.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors